Web notes  

September 2020
FUNDING OPPORTUNITIES- Back

COVID-19 Funding Opportunities

The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.


Institute for Clinical and Translational Research Boost and Propel Awards

Application deadline: September 14, 2020

These clinical research grants award ICTR Clinical Research Unit resources to investigators based on merit and willingness to be actively monitored by the Translational Research Evaluation Committee for study-specific milestones. Grants are for one year with possible renewal based on study progress and achieving pre-determined milestones.

BOOST awards are for junior investigators, first-time R01 awardees, K awardees, and KL2 scholars to generate pilot data for a larger grant submission or to supplement research funds for the K project.

PROPEL awards are intended for established investigators who are performing early stage clinical trials, deep phenotyping studies, or studies that address Maryland health priorities and can augment resources of a funded project or provide resources for small pilot and feasibility studies.

Any Johns Hopkins University faculty member interested in funding for a new or ongoing clinical research project is eligible to apply. All investigators must submit an application to a Johns Hopkins Institutional Review Board before beginning the application.

Apply by 11:59 pm, Monday, September 14. More information on the Boost and Propel Awards is available.


Parker B. Francis Fellowship in Pulmonary Research

Internal application deadline: September 10, 2020

The Parker B. Francis Fellowship in Pulmonary Research is intended to support the development of outstanding postdoctoral fellows or newly appointed assistant professors embarking on careers in pulmonary, critical care and sleep medicine. We seek to help them as they make the transition to independent, self-supporting, faculty members.

Eligibility & Requirements:

  • Scientists holding a relevant doctoral degree (e.g., M.D., Ph.D., Sc.D., D.V.M., Dr. P.H.) who are embarking on a career in clinical, laboratory or translational science related to Pulmonary, Critical Care and Sleep Medicine at a U.S. or Canadian university or research institution.
  • A citizen or permanent resident of the U.S. or Canada or have a permanent residency application on file at the time of application with the U.S. or Canadian Immigration Services.
  • A Ph.D. or other non-M.D. scientist no more than seven years beyond completion of their doctoral degree or an M.D. scientist no more than seven years beyond clinical training (i.e., residency, internship, clinical fellowship) at the time of application. Candidates with greater than seven years since the doctoral degree require approval for continued training from the Scientific Director of the PBF Fellowship Program.
  • Applicants must be approved by their department to apply for the PBF Fellowship. Institutions may have no more than three Parker B. Francis Fellows in a single department at a given time, a department may submit no more than two applications annually, and a mentor may sponsor only one application annually.
  • Individuals are not eligible for a PBF Fellowship if, at the time of application, they are or have been principal investigator on an NIH K or R series research award or other nationally competitive research award at the comparable level.
  • PBF Fellows in the second or third year of their Fellowship, who receive an NIH K or R series award or similar grant, may request approval to retain the Fellowship and to reallocate a portion of the Fellowship salary support to supplies or other research costs.
  • PBF Fellows are required to have at least 75 percent of their time available for research. Most successful candidates have two-to-five years of research experience and a minimum of two or three research publications at the time of fellowship application.

Internal Nomination Process:
Interested applicants should complete their application at the following link: https://jhu.infoready4.com/#competitionDetail/1816457

Requirements include:

  1. Proposal (maximum of two pages of text only, single spaced: 12-pt font and one-inch margins) Note: figures, tables, and other reference material may be included in addition to the 2 pg. text limit
  2. Curriculum Vitae of investigator, including current external research support and publications
  3. Budget (two pages maximum)

For more information, visit the Francis Family Foundation website. Questions? Comments? Email the Office of Foundation Relations at FoundationRelations@jhu.edu.


Michael J. Fox Foundation (MJFF) Challenge

No application deadline

The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.

The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson's disease (PD) field. The accumulation of aggregated alpha-synuclein is a pathological hallmark of PD and a priority target for drug development given its hypothesized contribution to neurodegeneration. In vivo imaging of alpha-synuclein pathology could be useful as a biomarker of the presence of disease and disease progression and as a pharmacodynamic tool for drug development. With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.

Contestants: Anyone is eligible for the prize who agrees to all contest rules. Contestants may be MJFF funded or not and can be from either academia or industry.

Contest rules:

  1. Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
  2. NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.

Criteria for winning: The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson's disease and/or another synucleinopathy. See below for more details on submission requirements.

Timeline: There is no deadline for submissions. The $2 million award will be issued to the first contestant who submits compelling evidence of a viable selective tracer and agrees to its widespread use. If no award is given by mid-2018, The Michael J. Fox Foundation will evaluate the state of the field and utility of such a prize.


Return to top of Funding Opportunities

 
   
September 2020 articles:
Essential Information for Human Subjects Research Teams Related to COVID-19
Coronavirus Research Billing Notices and FAQ
Hexcite (Excited for Healthcare) Applications Open
Introduction to Precision Medicine Analytics Online Course for Clinical Researchers Begins August 31
Research Billing Buzz eNewsletter
Managing Investigational Product Returns from Research Participants
Update to Organization Policy on Registration of Clinical Trials
Changes in HSR Recertification
Update on Insurance and Research Participant Financial Responsibility Information Sheet: Signature No Longer Required
Change in JHM IRB Review Fees for Commercially-Funded Studies
Data and Safety Monitoring Board Training Manual Now Available
Good Clinical Practice (GCP) Fundamentals: Understanding and Applying GCP to Human Subject Research
Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets
Changes to NIH-funded Human Subjects Research
Free Resources for Longitudinal Clinical Research Studies
JHM IRB Reliance Requests
Sharing Partnership for Innovative Research in Translation
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Clinical Research Network
 
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
COVID-19 Funding Opportunities
Parker B. Francis Fellowship in Pulmonary Research
Institute for Clinical and Translational Research Boost and Propel Awards
Michael J. Fox Foundation (MJFF) Challenge
Updated Guidance from NIH on COVID-19 Flexibilities for Applicants and Recipients
COVID-19 and Research Updates
New System to Request Outgoing Subawards
Point of Contact for NIH Loan Repayment Program
JHU SOM Update on NIH Policy on Foreign Involvement
Disclosure of Payments from Foreign Educational Institutions and Government Agencies
Institutional Letter of Support Required for Institutional Training Grant Applications
Notice to the Johns Hopkins Community Regarding the National Science Foundation Grant Reporting Requirement for Harassment Findings and Actions
Prohibited Mention of Prior Review for New Replacement Applications
NIH Policy on Foreign Component Involvement
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization
Why Project Outcomes Matter in your Interim and Final Research Performance Progress Report (RPPR)
NIH Matchmaker, A Tool For Finding Similar NIH Projects
NIH Video Tutorials on How to Apply for Grants

This Month's Departmental Listings

Upcoming Deadlines for September, October and November

Updates and Events at the Genetics Research Core Facilities
       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center